EUVIMEDEUVIMED entdecken
Crossref

Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy

Rui Wang, Wenqin Song, Jie Zhu, Xinyue Shao, Chenxiao Yang, Wei Xiong, Bing Wang, Pengfei Zhao, Meiwan Chen, Yongzhuo Huang

Journal of Controlled Release · 2024-04 · 368 · 84-96

DOI: 10.1016/j.jconrel.2024.02.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-04. Verfasst von Rui Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, China; State Key Laboratory of Drug Research, Shanghai Institute o…. Hauptthemen laut MEDLINE: Ferroptosis, Glioma. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis has emerged as a promising therapeutic approach for glioma. However, its efficacy is often compromised by the activated GPX4-reduced glutathione (GSH) system and the poor brain delivery efficiency of ferroptosis inducers. Therefore, suppression of the GPX4-GSH axis to induce the accumulation of lipid peroxides becomes an essential strategy to augment ferroptosis. In this study, we present a metalloimmunological strategy to target the GPX4-GSH axis by inhibiting the cystine/glutamate antiporter system (system Xc-) and glutathione synthesis. To achieve this, we developed a complex of diethyldithiocarbamate (DDC) chelated with copper and ferrous ions (DDC/Cu-Fe) to trigger T-cell immune responses in the tumor microenvironment, as well as to inhibit tumor-associated macrophages, thereby alleviating immunosuppression. To enhance brain delivery, the DDC/Cu-Fe complex was encapsulated into a hybrid albumin and lactoferrin nanoparticle (Alb/LF NP), targeting the nutrient transporters (e.g., LRP-1 and SPARC) overexpressed in the blood-brain barrier (BBB) and glioma cells. The Alb/LF NP effectively promoted the brain accumulation of DDC/Cu-Fe, synergistically induced ferroptosis in glioma cells and activated anticancer immunity, thereby prolonging the survival of glioma-bearing mice. The nanoformulation of DDC/Cu-Fe provides a promising strategy that combines ferroptosis and metalloimmunology for glioma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisGliomaAnimalsMiceBiomimeticsCopperAlbuminsDitiocarbCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

AlbuminAnti-gliomaBrain-targeted deliveryDiethyldithiocarbamate Cu/FeFerroptosisImmunogenic cell deathLactoferrinMetalloimmunology

Substanzen

CopperAlbuminsDitiocarb

Autor:innen und Institutionen

  • School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, China; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nanjing 210023, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528437, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Center of Clinical Pharmacology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310009, China. Electronic address: zhaopf0507@zju.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, R., Song, W., Zhu, J., Shao, X., Yang, C., Xiong, W., Wang, B., Zhao, P., Chen, M., & Huang, Y. (2024). Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy. Journal of Controlled Release, 368, 84-96. https://doi.org/10.1016/j.jconrel.2024.02.004

Vancouver

Wang R, Song W, Zhu J, Shao X, Yang C, Xiong W, et al. Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy. Journal of Controlled Release. 2024;368:84-96. doi:10.1016/j.jconrel.2024.02.004

BibTeX
@article{Wang2024,
  author = {Wang, Rui and Song, Wenqin and Zhu, Jie and Shao, Xinyue and Yang, Chenxiao and Xiong, Wei and Wang, Bing and Zhao, Pengfei and Chen, Meiwan and Huang, Yongzhuo},
  title = {Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {368},
  pages = {84--96},
  doi = {10.1016/j.jconrel.2024.02.004}
}
Kostenlos starten →